It might be speculated that IL-6 is also a potent activator of SOCS (suppressor of cytokine signaling) and thus increased activation of SOCS3 in skeletal muscles and liver leads to insulin resistance commonly observed in patients with obesity and diabetes [8]. This evidence concerns the gene IL6 and diabetes mellitus.